$14.68
0[0.00%]
At close: Apr 15
$14.68
0[0.00%]
After Hours: 5:22PM EDT
Merrimack Pharmaceuticals
(NASDAQ:MACK)Merrimack Pharmaceuticals Stock (NASDAQ:MACK), Quotes and News Summary
Merrimack Pharmaceuticals Stock (NASDAQ: MACK) stock price, news, charts, stock research, profile.
| Open | $14.700 |
| Close | $14.680 |
| Volume / Avg. | 141.836K / 121.575K |
| Day Range | 14.670 - 14.730 |
| 52 Wk Range | 11.530 - 15.890 |
| Market Cap | $213.326M |
| P/E Ratio | - |
| Dividend Yield | - |
| Exchange | NASDAQ |
| RSI | 53 |
| Short Interest | 7.08% |
| Days to Cover | 4.97 |
Financials
Quarterly
Annual
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
About Merrimack Pharmaceuticals Inc
Sector
Health Care
Industry
Biotechnology
Merrimack Pharmaceuticals Inc is a biotechnology company that discovers, develops, and commercialize...
Show More
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Merrimack Pharmaceuticals (MACK) stock?
You can purchase shares of Merrimack Pharmaceuticals (NASDAQ: MACK) through any online brokerage.
Who are Merrimack Pharmaceuticals's (MACK) competitors?
Other companies in Merrimack Pharmaceuticals’s space includes: Outlook Therapeutics (NASDAQ:OTLK), Innate Pharma (NASDAQ:IPHA), Galectin Therapeutics (NASDAQ:GALT), Adverum Biotechnologies (NASDAQ:ADVM) and bluebird bio (NASDAQ:BLUE).
What is the target price for Merrimack Pharmaceuticals (MACK) stock?
The latest price target for Merrimack Pharmaceuticals (NASDAQ: MACK) was reported by Baird on Monday, October 22, 2018. The analyst firm set a price target for 4.00 expecting MACK to fall to within 12 months (a possible -72.75% downside). 0 analyst firms have reported ratings in the last year.
Current Stock Price for Merrimack Pharmaceuticals (MACK)?
The stock price for Merrimack Pharmaceuticals (NASDAQ: MACK) is $14.68 last updated April 15, 2024 at 5:22 PM EDT.
Does Merrimack Pharmaceuticals (MACK) pay a dividend?
A quarterly cash dividend of $0.50 per share of Class A Common Stock. The quarterly cash dividend was payable on December 23, 2019 to stockholders of record on December 13, 2019.
When is Merrimack Pharmaceuticals (NASDAQ:MACK) reporting earnings?
Merrimack Pharmaceuticals’s Q1 earnings are confirmed for Thursday, May 2, 2024.
Is Merrimack Pharmaceuticals (MACK) going to split?
There is no upcoming split for Merrimack Pharmaceuticals.
What sector and industry does Merrimack Pharmaceuticals (MACK) operate in?
Merrimack Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.